Topic-Contributed Paper Session
Real-World Evidence in Health Technology Assessment: Landscape, Principal Usage, Case Studies, and Challenges & Opportunities
Biopharmaceutical Section co: Biometrics Sectionco: Business and Economic Statistics Section Applied
4 Presentations
10:35 AM - 10:55 AM
Dai Feng (AbbVie)
10:55 AM - 11:15 AM
Yingyi Liu (AbbVie)
11:15 AM - 11:35 AM
Xiang Zhang (CSL Behring)
Discussant
Haitao Chu (Pfizer)